Effect of different doses of oral olanzapine to prevent postoperative nausea and vomiting after laparoscopic surgery in high-risk patients: A randomised controlled trial
Restricted accessResearch articleFirst published online May, 2026
Effect of different doses of oral olanzapine to prevent postoperative nausea and vomiting after laparoscopic surgery in high-risk patients: A randomised controlled trial
We conducted this study to compare the efficacy of oral 10 and 5 mg olanzapine for the prevention of postoperative nausea and vomiting.
Methods:
Notably, 135 female patients between the ages of 18 and 50 years, classed as American Society of Anaesthesiologists I and II, who underwent elective laparoscopic gynaecological surgery under general anaesthesia were randomly assigned to one of three groups (45 each) to receive perioperative 5 or 10 mg oral olanzapine (OL5 and OL10 groups), or a placebo (in the control group). Postoperation, we recorded the occurrence and severity of postoperative nausea and vomiting within 24 h, the number of patients who received antiemetics and any associated side effects.
Results:
Postoperative nausea was more prevalent in the control group (23 patients) than in OL5 and OL10 groups (13 and three patients, respectively); Group OL10 had the lowest severity of nausea. There was no incidence of vomiting in the OL10 group, and only one patient required antiemetics; in the OL5 group, three patients required antiemetics and eight patients in the control group needed antiemetics.
Conclusion:
Olanzapine 10 mg had a higher effect than the lower concentration of 5 mg or control in reducing the incidence of postoperative nausea and vomiting in the first postoperative 24 h.
ApfelCCKorttilaKAbdallaM, et al2004A factorial trial of six interventions for the prevention of postoperative nausea and vomitingN Engl J Med350 (24) 2441–2451.
2.
BymasterFPCalligaroDOFalconeJF, et al1996Radioreceptor binding profile of the atypical antipsychotic olanzapineNeuropsychopharmacology14 (2) 87–96.
3.
ChoJSKimEJLeeJH, et al2016Betahistine reduces postoperative nausea and vomiting after laparoscopic gynaecological surgeryMinerva Anestesiol82 (6) 649–656.
4.
De MoraisLCSousaAMFloraGF, et al2018Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: A double-blind, randomized trialActa Anaesthesiol Scand62 (4) 483–492.
5.
EberhartLHHögelJSeelingW, et al2000Evaluation of three risk scores to predict postoperative nausea and vomitingActa Anaesthesiol Scand44 (4) 480–488.
GanTJ2002Postoperative nausea and vomiting–can it be eliminated?JAMA287 (10) 1233–1236.
8.
GanTJBelaniKGBergeseS, et al2020Fourth Consensus guidelines for the management of postoperative nausea and vomitingAnesth Analg131 (2) 411–448.
9.
GrigioTRTimmermanHMartinsJVB, et al2023Olanzapine as an add-on, pre-operative anti-emetic drug for postoperative nausea or vomiting: A randomised controlled trialAnaesthesia78 (10) 1206–1214.
10.
HashimotoHAbeMTokuyamaO, et al2020Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncol21 (2) 242–249.
11.
HillRPLubarskyDAPhillips-ButeB, et al2000Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placeboAnesthesiology92 (4) 958–967.
12.
HockingCMKichenadasseG2014Olanzapine for chemotherapy-induced nausea and vomiting: A systematic reviewSupport Care Cancer22 (4) 1143–1151.
13.
HymanJBParkCLinHM, et al2020Olanzapine for the prevention of postdischarge nausea and vomiting after ambulatory surgery: A randomized controlled trialAnesthesiology132 (6) 1419–1428.
14.
JabaleyCSGrayDWBudhraniGS, et al2020chronic atypical antipsychotic use is associated with reduced need for postoperative nausea and vomiting rescue in the postanesthesia care unit: A propensity-matched retrospective observational studyAnesth Analg130 (1) 141–150.
15.
KienbaumPSchaeferMSWeibelS, et al2022Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomitingAnaesthesist71: 123–128.
16.
MacintyrePELoadsmanJAScottDA2011Opioids, ventilation and acute pain managementAnaesth Intensive Care39 (4) 545–558.
17.
MatthewsC2017A review of nausea and vomiting in the anaesthetic and post anaesthetic environmentJ Perioper Pract27: 224–227.
18.
McCormackPLWisemanLR2004Olanzapine: A review of its use in the management of bipolar I disorderDrugs64: 2709–2726.
19.
MizukamiNYamauchiMKoikeK, et al2014Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: A randomized, double-blind, placebo-controlled studyJ Pain Symptom Manage47 (3) 542–550.
20.
NavariRMEinhornLHPassikSD, et al2005A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group studySupport Care Cancer13 (7) 529–534.
21.
NavariRMQinRRuddyKJ, et al2016Olanzapine for the prevention of chemotherapy-induced nausea and vomitingN Engl J Med375 (2) 134–142.
22.
PassikSDNavariRMJungSH, et al2004A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: A Hoosier Oncology Group studyCancer Invest22 (3) 383–388.
23.
RoilaFHerrstedtJAaproM, et al2010Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conferenceAnn Oncol21: 232–243.
24.
SaudemontGProd’HommeCDa SilvaA, et al2020The use of olanzapine as an antiemetic in palliative medicine: A systematic review of the literatureBMC Palliat Care19 (1) 56.
25.
TanLLiuJLiuX, et al2009Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomitingJ Exp Clin Cancer Res28 (1) 131.
TienchaianandaPNipondhkitWManeenilK, et al2019A randomized, double-blind, placebo-controlled study evaluating the efficacy of a combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamideAnn Palliat Med8 (4) 372–380.
28.
TramèrMR2004Strategies for postoperative nausea and vomitingBest Pract Res Clin Anaesthesiol18 (4) 693–701.
29.
WeibelSSchaeferMSRajD, et al2021Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: An abridged Cochrane network meta-analysisAnaesthesia76 (7) 962–973.
30.
ZhangZZhangYChenG, et al2018Olanzapine-based triple regimens versus neurokinin-1 receptor antagonist-based triple regimens in preventing chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy: A network meta-analysisOncologist23 (5) 603–616.
